DAMASCUS, MARYLAND, UNITED STATES, October 12, 2023 /EINPresswire.com/ — The Sarcoma Foundation of America (SFA) is proud to announce the recipient of its inaugural Last Mile Sarcoma Research Award. Inga-Marie Schaefer, MD, of Brigham and Girls’s Hospital in Boston, Mass., has been introduced this prestigious grant for her venture titled “Identification of Therapeutic Methods to Restore Cell Cycle Management in GIST.”
The Last Mile Sarcoma Research Award, named to coincide with the analysis funding raised from SFA’s Race to Treatment Sarcoma sequence, was developed to leverage bigger authorities {dollars} for sarcoma analysis. This grant award, a first-of-its-kind from SFA, gives $150,000 in funding to assist strengthen the long run proposal for a Nationwide Most cancers Institute (NCI) R01 grant, finally, bringing the analysis during the last mile to qualify for funding.
Inga-Marie Schaefer, MD, is Assistant Professor in Pathology at Harvard Medical Faculty and Affiliate Pathologist at Brigham and Girls’s Hospital. Dr. Schaefer can also be Affiliate School within the Division of Pathology at Dana-Farber Most cancers Institute. She is a board member of the Connective Tissue Oncology Society (CTOS) and an editorial board member of the scientific journal Genes, Chromosomes & Most cancers.
Dr. Schaefer earned her medical diploma from the Georg-August College in Göttingen, Germany, and the College of Bern, Switzerland. She educated in Anatomic Pathology on the College Hospital Göttingen and at Brigham and Girls’s Hospital. Throughout her postdoctoral research at Brigham and Girls’s Hospital and Harvard Medical Faculty, she characterised mechanisms of Gastrointestinal Stromal Tumors (GIST) genomic development and recognized early inactivation of the MAX tumor suppressor as a recurrent occasion in GIST. In 2018, she obtained board certification in Anatomic Pathology and have become college within the Division of Pathology at Brigham and Girls’s Hospital.
Dr. Schaefer leads a analysis program centered on the biology, genetics, and molecular mechanisms of sarcomas with the purpose of creating novel therapeutics. She has been awarded the Sperling Household Fellowship in Precision Healthcare, the Liddy Shriver Early Profession Research Award, and the Fred Sanfilippo-ASIP Visiting Lectureship Award.
Gastrointestinal Stromal Tumors (GIST) characterize a difficult subset of sarcomas, necessitating modern options for therapy. Dr. Schaefer’s analysis endeavors to deepen our comprehension of GIST and pioneer novel therapeutic approaches geared toward reinstating cell cycle management, doubtlessly main to enhanced affected person outcomes.
“The Sarcoma Foundation of America is happy to award this inaugural Last Mile Research Grant to Dr. Schaefer,” says Brandi Felser, SFA CEO. “Because the main non-public funder of analysis within the sarcoma group, this award displays SFA’s dedication to sarcoma analysis and its mission to advance the sphere.”
For extra details about SFA and its analysis initiatives, go to www.curesarcoma.org/sarcoma-research.
# # #
Concerning the Sarcoma Foundation of America
The Sarcoma Foundation of America (SFA), a 501(c)(3) nonprofit charitable group, is an advocate for elevated analysis to discover new and higher therapies with which to deal with sufferers with sarcoma. The group raises cash to privately fund grants for sarcoma researchers and conducts training and advocacy efforts on behalf of sarcoma sufferers. For extra info, please go to www.curesarcoma.org.
About Sarcoma
Sarcoma is a uncommon most cancers in adults (1 % of all grownup cancers) however moderately prevalent in kids (about 15% of all childhood cancers). At anyone time, 200,000 sufferers and their households are fighting sarcoma. Yearly, almost 17,370 new circumstances are recognized and greater than 7,280 individuals die from the illness.
Brandi Felser
Sarcoma Foundation of America
+1 301-253-8687 ext. 116
e mail us right here
Go to us on social media:
Twitter
